scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "COST effectiveness"

1 - 10 of 154,197 results for
 "COST effectiveness"
Results per page:

Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios.

Publication Type: Academic Journal

Source(s): Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jun; Vol. 24 (6), pp. 759-769. Date of Electronic Publication: 2021 Mar 31.

Abstract: Objectives: Onasemnogene Abeparvovec-xioi (AVXS-101) is a gene therapy intended for curative treatment of spinal muscular atrophy (SMA) with an expected price of around €2 000 000. The goal of this study is to perform a cost-effectiveness analysis of t...

View details

Building a Practical Quantum Computer.

Publication Type: Periodical

Source(s): Communications of the ACM. Jul2022, Vol. 65 Issue 7, p15-17. 3p. 1 Color Photograph.

Authors:

Abstract: The article discusses quantum computing and the struggles involved with devising a quantum computer for cost effective practical use. The article examines the use of noisy, intermediate-scale quantum (NISQ) circuits, the cooling of superconducting qubi...

View details

Too much can be as bad as too little: product update strategy for online digital platform complementors.

Publication Type: Academic Journal

Source(s): Industrial & Corporate Change; Dec2022, Vol. 31 Issue 6, p1494-1516, 23p, 1 Diagram, 7 Charts, 1 Graph

Authors:

Abstract: Copyright of Industrial & Corporate Change is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users...

View details

Scale-free-modeling (harmonic) vibrational frequencies: Assessing accuracy and cost-effectiveness by CBS extrapolation.

Publication Type: Academic Journal

Source(s): Journal of Chemical Physics; 11/7/2022, Vol. 157 Issue 17, p1-20, 20p

Abstract: Copyright of Journal of Chemical Physics is the property of American Institute of Physics and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users m...

View details

To what extent patents for Covid-19 mRNA vaccines are based on public research and taxpayers' funding? A case study on the privatization of knowledge.

Publication Type: Academic Journal

Source(s): Industrial & Corporate Change; Oct2022, Vol. 31 Issue 5, p1137-1151, 15p

Authors:

Abstract: Copyright of Industrial & Corporate Change is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users...

View details

Publication Type: Academic Journal

View details

Private corruption: An integrated organizational model.

Publication Type: Academic Journal

Source(s): European Management Review. Nov2022, Vol. 19 Issue 3, p476-486. 11p.

Abstract: This study presents an integrated view of private corruption as an organizational issue. Two separate approaches are exploited aimed at understanding the factors that affect the agent's engagement in corruption and the features of the organizational dy...

View details

Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective.

Publication Type: Academic Journal

Source(s): PharmacoEconomics. Dec2022, Vol. 40 Issue 12, p1247-1259. 13p.

Abstract: Background and Objective: Pembrolizumab plus cisplatin and fluorouracil demonstrated superior efficacy and comparable safety compared with fluorouracil and cisplatin (FP) as first-line treatment for locally advanced unresectable or metastatic carcinoma...

View details

Publication Type: Academic Journal

View details

Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.

Publication Type: Academic Journal

Source(s): PharmacoEconomics. Dec2022, Vol. 40 Issue 12, p1187-1205. 19p.

Abstract: Objective: The aim of this study was to model the potential long-term disease progression and pharmacoeconomic value of sacubitril/valsartan for the treatment of essential hypertension from a Chinese healthcare system perspective. Methods: A Markov coh...

View details
sponsored